ProjectBRIGHT- Studie

Basic data

Title:
BRIGHT- Studie
Duration:
01/05/2024 to 30/06/2027
Abstract / short description:
A phase 2, double blind randomizes placebo controlles study to evaluate the safety and efficacy of multiple doses of LT3001 drug product in subjects with acute ischemic stroke

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurovascular Diseases
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Farnborough, United Kingdom
Help

will be deleted permanently. This cannot be undone.